Suppr超能文献

对镍的口服耐受性需要CD4+不变自然杀伤T细胞来实现耐受性的感染性传播以及特异性调节性T细胞的诱导。

Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells.

作者信息

Roelofs-Haarhuis Karin, Wu Xianzhu, Gleichmann Ernst

机构信息

Institut für Umweltmedizinische Forschung (IUF), Heinrich Heine University, Düsseldorf, Germany.

出版信息

J Immunol. 2004 Jul 15;173(2):1043-50. doi: 10.4049/jimmunol.173.2.1043.

Abstract

Previously, oral administration of nickel to C57BL/6 wild-type (WT) mice was shown to render both their splenic T cells and APCs (i.e., T cell-depleted spleen cells) capable of transferring nickel tolerance to naive syngeneic recipients. Moreover, sequential adoptive transfer experiments revealed that on transfer of tolerogenic APCs and immunization, the naive T cells of the recipients differentiated into regulatory T (Treg) cells. Here, we demonstrate that after oral nickel treatment Jalpha18(-/-) mice, which lack invariant NKT (iNKT) cells, were not tolerized and failed to generate Treg cells. However, transfer of APCs from those Jalpha18(-/-) mice did tolerize WT recipients. Hence, during oral nickel administration, tolerogenic APCs are generated that require iNKT cell help for the induction of Treg cells. To obtain this help, the tolerogenic APCs must address the iNKT cells in a CD1-restricted manner. When Jalpha18(-/-) mice were used as recipients of cells from orally tolerized WT donors, the WT Treg cells transferred the tolerance, whereas WT APCs failed to do so, although they proved tolerogenic on transfer to WT recipients. However, Jalpha18(-/-) recipients did become susceptible to the tolerogenicity of transferred WT APCs when they were reconstituted with IL-4- and IL-10-producing CD4(+) iNKT cells. We conclude that CD4(+) iNKT cells are required for the induction of oral nickel tolerance and, in particular, for the infectious spread of tolerance from APCs to T cells. Once induced, these Treg cells, however, can act independently of iNKT cells.

摘要

此前研究表明,给C57BL/6野生型(WT)小鼠口服镍后,其脾脏T细胞和抗原呈递细胞(即去除T细胞的脾细胞)都能够将镍耐受性传递给同基因的未致敏受体。此外,序贯性过继转移实验显示,在转移致耐受性抗原呈递细胞并进行免疫后,受体的未致敏T细胞分化为调节性T(Treg)细胞。在此,我们证明,口服镍处理后的Jalpha18(-/-)小鼠(缺乏恒定自然杀伤T细胞(iNKT细胞))未产生耐受性,也未能生成Treg细胞。然而,来自这些Jalpha18(-/-)小鼠的抗原呈递细胞转移后却使WT受体产生了耐受性。因此,在口服镍的过程中,会产生致耐受性抗原呈递细胞,其诱导Treg细胞需要iNKT细胞的帮助。为获得这种帮助,致耐受性抗原呈递细胞必须以CD1限制性方式作用于iNKT细胞。当Jalpha18(-/-)小鼠作为口服耐受的WT供体细胞的受体时,WT Treg细胞转移了耐受性,而WT抗原呈递细胞则未能如此,尽管它们转移到WT受体时被证明具有耐受性。然而,当用产生IL-4和IL-10的CD4(+) iNKT细胞重建Jalpha18(-/-)受体时,它们确实变得易受转移的WT抗原呈递细胞耐受性的影响。我们得出结论,CD4(+) iNKT细胞是诱导口服镍耐受性所必需的,特别是对于耐受性从抗原呈递细胞向T细胞的感染性传播而言。然而,一旦诱导产生,这些Treg细胞可以独立于iNKT细胞发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验